DreaMed Diabetes
Artificial pancreas algorithm for insulin delivery system
DreaMed Diabetes has raised €4.9M across 2 funding rounds from 2 investors, most recently a Early VC round in Jul 2016. Based in Petah Tikva, Israel; founded 2014; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€4.9M
€4,858,909
Funding rounds
2
Investors
2
distinct backers
Active since
2015-04
latest 2016-07
Funding by year
EUR raised per yearDreaMed Diabetes — funding by year — interactive chart.
Data table
| DreaMed Diabetes — funding by year | |
|---|---|
| 2015 | €1.9M |
| 2016 | €3.0M |
Signals
High confidenceRaise-next likelihood9
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood7
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2016-07-01 | Early VC | €3.0M | Norma Investments | View deal → |
| 2015-04-01 | Seed | €1.9M | Medtronic | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Trax€789MIsrael · Software
Global coverage: FundingData